NCT05975580View on ClinicalTrials.gov

Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 29, 2023

Primary Completion Date

April 2, 2027

Study Completion Date

July 31, 2027

Conditions
Obesity
Interventions
DRUG

Topiramate

Topiramate is an anticonvulsant (antiepilepsy) drug. IUPAC ID: 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate

DRUG

Phentermine

Phentermine belongs to a class of drugs called anorectics, also known as appetite suppressants. IUPAC name 2-methyl-1-phenylpropan-2-amine

DRUG

Placebo

Placebo is an inactive substance.

Trial Locations (1)

92868

RECRUITING

University of California Irvine Medical Center, Orange

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of California, Irvine

OTHER